Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign

Clinical Infectious Diseases

Volumn 44, Issue 3, 2007, Pages 373-379

  Greene, Reginald E ^a   Schlamm, Haran T ^c   Oestmann, Jörg W ^h   Stark, Paul ^d   Durand, Christine ⁱ   Lortholary, Olivier ^j   Wingard, John R ^e   Herbrecht, Raoul ^l   Ribaud, Patricia ^k   Patterson, Thomas F ^f   Troke, Peter F ^m   Denning, David W ⁿ   Bennett, John E ^g   De Pauw, Ben E ^o   Rubin, Robert H ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Pf Izer Global Research and Development   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ HÔPITAL DU BOCAGE   (France)

^j INSTITUT PASTEUR   (France)

^k SAINT LOUIS HOSPITAL   (France)

^l HÔPITAL DE HAUTEPIERRE   (France)

^m PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

ⁿ UNIVERSITY OF MANCHESTER   (United Kingdom)

^o RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CHILD; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LUNG; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846418017     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/509917     Document Type: Article

References (54)

1. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100:4358-66.
2. De La Rosa GR, Champlin RE, Kontoyiannis DP. Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients. Transpl Infect Dis 2002; 4:3-9.
3. Perea S, Patterson TF. Invasive Aspergillus infections in hematologic malignancy patients. Semin Respir Infect 2002; 17:99-105.
4. Dasbach EJ, Davies GM, Teutsch SM. Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis 2000; 31:1524-8.
5. Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis: disease spectrum, treatment practices, and outcomes. Medicine (Baltimore) 2000; 79:250-60.
6. Oren I, Goldstein N. Invasive pulmonary aspergillosis. Curr Opin Pulm Med 2002; 8:195-200.
7. Caillot D, Mannone L, Cuisenier B, Couaillier JF. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clin Microbiol Infect 2001; 7(Suppl 2):54-61.
8. Stevens DA, Ran VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis 2000; 30:696-709.
9. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26:781-803.
10. Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001;33:1824-33.
11. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408-15.
12. Saugier-Veber P, Devergie A, Sulahian A, et al. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: result of a 5 year retrospective study. Bone Marrow Transplant 1993; 12:121-4.
13. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121:1988-99.
14. Reichenberger F, Habicht JM, Gratwohl A, Tamm M. Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J 2002; 19:743-55.
15. Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of Aspergillus in BAL. Chest 2002; 121:1171-6.
16. Comstock GW, Palmer CE, Stone RW, Goodman NL. Fungi in the sputum of normal men. Mycopathol Mycol Appl 1974; 54:55-62.
17. Nalesnik MA, Myerowitz RL, Jenkins R, Lenkey J, Herbert D. Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 1980; 11:370-6.
18. Cairns MR, Durack DT. Fungal pneumonia in the immunocompromised host. Semin Respir Infect 1986; 1:166-85.
19. Masur H, Shelhamer J, Parrillo JE. The management of pneumonias in immunocompromised patients. JAMA 1985; 253:1769-73.
20. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992; 86:243-8.
21. Hope W, Walsh T, Denning D. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5:609-22.
22. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97:1604-10.
23. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20:1898-906.
24. Tanriover MD, Metan G, Altun B, Hascelik G, Uzun O. False positivity for Aspergillus antigenemia related to the administration of piperacillin/tazobactam. Eur J Intern Med 2005; 16:489-91.
25. Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004; 38:917-20.
26. Walsh TJ, Shoham S, Petraitiene R, et al. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004; 42:4744-8.
27. Viscoli C, Machetti M, Cappellano P, et al. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillintazobactam. Clin Infect Dis 2004; 38:913-6.
28. Sulahian A, Touratier S, Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003; 349:2366-7.
29. Hauggaard A, Ellis M, Ekelund L. Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis. Acta Radiol 2002; 43:292-8.
30. Greene R. The radiological spectrum of pulmonary aspergillosis. Med Mycol 2005;43(Suppl 1):S147-54.
31. Orr DP, Myerowitz RL, Dubois PJ. Patho-radiologic correlation of invasive pulmonary aspergillosis in the compromised host. Cancer 1978; 41:2028-39.
32. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985; 157:611-4.
33. Primack SL, Hartman TE, Lee KS, Muller NL. Pulmonary nodules and the CT halo sign. Radiology 1994; 190:513-5.
34. Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19:253-9.
35. Blum U, Windfuhr M, Buitrago-Tellez C, Sigmund G, Herbst EW, Langer M. Invasive pulmonary aspergillosis: MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest 1994; 106:1156-61.
36. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15:139-47.
37. Burch PA, Karp JE, Merz WG, Kuhlman JE, Fishman EK. Favorable outcome of invasive aspergillosis in patients with adult acute leukemia. J Clin Oncol 1987; 5:1985-93.
38. Kami M, Kishi Y, Hamaki T, et al. The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis: an autopsy-based retrospective study of 48 patients. Mycoses 2002; 45:287-94.
39. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14.
40. Leader JK, Warfel TE, Fuhrman CR, et al. Pulmonary nodule detection with low-dose CT of the lung: agreement among radiologists. AJR Am J Roentgenol 2005; 185:973-8.
41. Austin JH, Muller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996;200:327-31.
42. Greaves SM, Hart EM, Brown K, Young DA, Batra P, Aberle DR. Pulmonary thromboembolism: spectrum of findings on CT. AJR Am J Roentgenol 1995; 165:1359-63.
43. Curtis AM, Smith GJ, Ravin CE. Air crescent sign of invasive asper-gillosis. Radiology 1979; 133:17-21.
44. SAS/STAT user's guide, version 8. Gary NC: SAS Institute, 1999.
45. Logan PM, Primack SL, Miller RR, Muller NL. Invasive aspergillosis of the airways: radiographie, CT, and pathological findings. Radiology 1994; 193:383-8.
46. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000;30:851-6.
47. Lee YR, Choi YW, Lee KJ, Jeon SC, Park CK, Heo JN. CT halo sign: the spectrum of pulmonary diseases. Br J Radiol 2005; 78:862-5.
48. Chamilos G, Maron E, Lewis R, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005; 41:60-6.
49. Weisser M, Rausch C, Droll A, et al. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis 2005; 41:1143-9.
50. Francesconi A, Kasai M, Petraitiene R, et al. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol 2006; 44:2475-80.
51. Horger M, Einsele H, Schumacher U, et al. Invasive pulmonary aspergillosis: frequency and meaning of the "hypodense sign" on unenhanced CT. Br J Radiol 2005; 78:697-703.
52. Wald A, Leisenring W, Burick JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175:1459-66.
53. Boeckh M, Marr KA. Infection in hematopoietic stem cell transplantation. In: Rubin RH, Young LS, eds. Clinical approach to the compromised host. 4th ed. New York: Kluwer Academic/Plenum Publishers, 2002:527-71.
54. Horger M, Hebart H, Einsele H, et al. Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome? Eur J Radiol 2005; 55:437-44.